M
Marianne S. Elston
Researcher at University of Auckland
Publications - 65
Citations - 1683
Marianne S. Elston is an academic researcher from University of Auckland. The author has contributed to research in topics: Pheochromocytoma & Germline mutation. The author has an hindex of 18, co-authored 59 publications receiving 1445 citations. Previous affiliations of Marianne S. Elston include University of Auckland, Faculty of Medical and Health Sciences & Waikato Hospital.
Papers
More filters
Journal ArticleDOI
Clinical presentation and penetrance of Pheochromocytoma/ Paraganglioma syndromes.
Diana E. Benn,Anne Paule Gimenez-Roqueplo,Jennifer R. Reilly,Jérôme Bertherat,John Burgess,Karen Byth,Michael S. Croxson,Patricia L. M. Dahia,Marianne S. Elston,Oliver Gimm,David Henley,Philippe Herman,Victoria Murday,Patricia Niccoli-Sire,Janice L. Pasieka,Vincent Rohmer,Katherine M. Tucker,Xavier Jeunemaitre,Deborah J. Marsh,Pierre-François Plouin,Bruce G. Robinson,Bruce G. Robinson +21 more
TL;DR: SDHB mutation carriers were more likely than SDHD mutation carriers to develop extraadrenal pheochromocytomas and malignant disease, whereas SD HD mutation carriers had a greater propensity to develop head and neck paragangliomas and multiple tumors.
Journal ArticleDOI
Factitious Graves' Disease Due to Biotin Immunoassay Interference—A Case and Review of the Literature
Marianne S. Elston,Marianne S. Elston,Shekhar Sehgal,Stephen Du Toit,Tania Yarndley,John V. Conaglen,John V. Conaglen +6 more
TL;DR: Biotin ingested in moderate to high doses can cause immunoassay interference and has the potential to affect a wide range of analytes, so it is important to be aware of this interaction to prevent misdiagnosis and inappropriate treatment.
Journal ArticleDOI
Wnt pathway inhibitors are strongly down-regulated in pituitary tumors
Marianne S. Elston,Anthony J. Gill,Anthony J. Gill,John V. Conaglen,Adele Clarkson,Adele Clarkson,Janet M. Shaw,Andrew J.J. Law,Raymond J. Cook,Nicholas S. Little,Roderick J. Clifton-Bligh,Bruce G. Robinson,Kerrie L. McDonald +12 more
TL;DR: The data suggest that WIF1 may be a tumor suppressor, specifically in nonfunctioningpituitary tumors, and that the Wnt pathways are important in pituitary tumorigenesis.
Journal ArticleDOI
Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
Michelle Houang,Adele Clarkson,Adele Clarkson,Loretta Sioson,Loretta Sioson,Marianne S. Elston,Marianne S. Elston,Roderick J. Clifton-Bligh,Roderick J. Clifton-Bligh,Michael Dray,Michael Dray,Dominique Ranchère-Vince,Anne-Valérie Decouvelaere,Arnaud de la Fouchardière,Anthony J. Gill,Anthony J. Gill,Anthony J. Gill +16 more
TL;DR: It is concluded that neither FGF23 nor SSTR2A expression are specific for the diagnosis of PMT, however both stains are highly sensitive.
Journal ArticleDOI
Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas
Marianne S. Elston,Marianne S. Elston,Anthony J. Gill,Anthony J. Gill,John V. Conaglen,Adele Clarkson,Raymond J. Cook,Nicholas S. Little,Bruce G. Robinson,Bruce G. Robinson,Roderick J. Clifton-Bligh,Roderick J. Clifton-Bligh,Kerrie L. McDonald,Kerrie L. McDonald +13 more
TL;DR: E-cadherin was frequently lost at the cytoplasmic membrane but detected in the nucleus, suggesting that cleavage of the extracellular domain and nuclear translocation of E-cADherin is a common event that may determine local invasion in pituitary adenomas.